// App-Quantinova.ai

: Characterization of Transcriptional Alterations Leading to Aberrant Myeloid Differentiation in Myelodysplastic Syndromes

Researchers

Presenter

  • Aintzane Diaz-Mazkiaran

Principal Investigators

  • Guillermo Serrano

  • Paula Garcia-Olloqui

  • Nerea Berastegui

  • Marina Ainciburu

  • Ana Alfonso Pierola

  • Amaia Vilas-Zornoza

  • Patxi San Martin-Uriz

  • Jose Maria Lamo De Espinosa

  • Mikel San Julián

  • Pamela Acha

  • Francesc Sole

  • Tamara Jimenez

  • Félix López Cadenas

  • Maria Diez-Campelo

  • Antonieta Molero

  • Maria Julia Montoro

  • David Valcarcel

  • Teresa Ezponda

  • Mikel Hernaez

  • Felipe Prosper

Medical Centers

  • Department of Hematology, University Hospital Vall d'Hebron, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), BARCELONA, Spain

  • Clinica Universidad De Navarra, Pamplona, ESP

  • MDS Research Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain

  • Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, IDISNA, Pamplona, Spain

  • Hemato-Oncology Program, CIMA Universidad de Navarra, Pamplona, Spain

  • Hematology and Cell Therapy Department, Clínica Universidad de Navarra, Pamplona, Spain

  • Department of Hematology. Salamanca-IBSAL university hospital, Salamanca, Spain

  • Department of Oncology-Hematology, Centro de Investigación Médica Aplicada (CIMA), Navarra university-IDISNA. Centro de Investigación Biomédica en Red de Cáncer, CIBERONC. Clínica Universidad de Navarra, Pamplona, Spain

  • Hematology/Oncology, CIMA Universidad de Navarra, IdISNA, Pamplona, Spain

  • Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain

  • TECNUN School of Engineering, University of Navarra, San Sebastian, , Spain., San Sebastian, Spain

  • Department of Hematology, University Hospital Vall d'Hebron, University Autonoma of Barcelona (UAB), Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Navarra Institute for Health Research (IdiSNA), Pamplona, Spain

  • Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain

  • Hematology, Hospital Universitario de Salamanca-IBSAL, Salamanca, España., Salamanca, Spain

  • Hematology-Oncology Program, Universidad de Navarra, CIMA, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelodysplastic Syndrome

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved